[1]
Ferrajoli, A., O’Brien, S., O’Brien, S., Faderl1, S., Faderl1, S., Wierda, W., Wierda, W., Reuben, J., Reuben, J., Keating, M. and Keating, M. 2009. Lenalidomide: an emerging option in chronic lymphocytic leukemia. Hematology Meeting Reports (formerly Haematologica Reports). 3, 3 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v3i3.582.